The mission of this Division is to deliver the promise of personalized medicine to cancer patients, by using the most advanced imaging techniques in conjunction with clinical parameters and other biomarkers. His main research areas include prostate cancer (multiparametric MRI, in-bore MRI–targeted biopsy) and whole-body MRI (prostate and breast cancer, multiple myeloma, and cancer screening in high-risk and general populations). He is author of more than 115 articles in peer-reviewed journals, 13 books and several book chapters and he is principal investigator in more than 25 clinical trials, some of them multicentric with international collaborations. Prof. Petralia is president of the MRI working group of the Italian Society of Radiology (SIRM), sits in the executive board of the International Cancer Imaging Society (ICIS) and he is deeply involved in teaching in national and international meetings.